Literature DB >> 25728504

Accuracy of Echocardiographic Cardiac Index Assessment in Subjects with Preserved Left Ventricular Ejection Fraction.

Micha T Maeder1,2,3, Sofie Karapanagiotidis1,2, Elizabeth M Dewar1,2, David M Kaye1,2.   

Abstract

INTRODUCTION: We aimed to determine the accuracy of the echocardiographic assessment of cardiac index (CI) in subjects with preserved left ventricular ejection fraction (LVEF).
METHODS: Thirty-three subjects with LVEF >50%, normal sinus rhythm, and a broad spectrum of hemodynamic profiles underwent echocardiography immediately followed by right heart catheterization. As gold standards, CI was assessed using thermodilution [CI (TD)] and the Fick method [CI (F)]. Echocardiographic CI was assessed by four methods: from the left ventricular outflow tract (LVOT) velocity time integral and the LVOT diameter as measured [CI (LVOTm)] as well as estimated from body surface area [CI (LVOTe)], and from stroke volume indices assessed using the biplane [CI (BP)] and monoplane [CI (MP)] methods.
RESULTS: The mean CI (TD), CI (F), CI (LVOTm), CI (LVOTe), CI (BP), and CI (MP) were 3.0 ± 0.9, 3.1 ± 0.7, 2.8 ± 0.6, 3.3 ± 0.6, 2.0 ± 0.6, and 2.2 ± 0.7 L/min/m(2) . There were modest correlations between CI (TD) and CI (F) and all four noninvasive measures of CI with r(2) values ranging from 0.09 to 0.30. CI (LVOTm) underestimated CI (TD) and CI (F) by 0.3 and 0.3 L/min/m(2) , CI (LVOTe) overestimated CI (TD) and CI (F) by 0.3 and 0.2 L/min/m(2) , and CI (BP) and CI (MP) underestimated CI (TD) and CI (F) by 1.1 and 1.1 L/min/m(2) and 0.9 and 0.9 L/min/m(2) , respectively, with large limits of agreement for all comparisons.
CONCLUSIONS: In subjects with nondilated left ventricles with preserved LVEF, flow- or volume-based measures of CI by 2D echocardiography may not accurately reflect CI (TD) and CI (F). Further larger studies are required to verify our findings and to evaluate the accuracy of contrast and 3D echocardiography in this setting.
© 2015, Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac output; echocardiography; ejection fraction; preserved; right heart catheterization

Mesh:

Year:  2015        PMID: 25728504     DOI: 10.1111/echo.12928

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

1.  Comparisons of Noninvasive Methods Used to Assess Exercise Stroke Volume in Heart Failure with Preserved Ejection Fraction.

Authors:  Erik H Van Iterson; Thomas P Olson; Barry A Borlaug; Bruce D Johnson; Eric M Snyder
Journal:  Med Sci Sports Exerc       Date:  2017-09       Impact factor: 5.411

2.  Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder.

Authors:  Benjamin W Van Tassell; Peter Westman; Cory Trankle; Sade Johns; Dinesh Kadariya; Leo Buckley; Salvatore Carbone; Antonio Abbate; Frederick Gerard Moeller
Journal:  J Cardiovasc Pharmacol       Date:  2019-12       Impact factor: 3.105

3.  Asymptomatic Hypotension in a Patient with Catheter-related Right Atrial Thrombus.

Authors:  Hillary E Davis; Michael Lu; Scott J Cameron; Ryan Bodkin
Journal:  Clin Pract Cases Emerg Med       Date:  2018-01-09

4.  Reduced exercise capacity in patients with systemic sclerosis is associated with lower peak tissue oxygen extraction: a cardiovascular magnetic resonance-augmented cardiopulmonary exercise study.

Authors:  Daniel S Knight; Vivek Muthurangu; James T Brown; Tushar Kotecha; Jennifer A Steeden; Marianna Fontana; Christopher P Denton; J Gerry Coghlan
Journal:  J Cardiovasc Magn Reson       Date:  2021-10-28       Impact factor: 5.364

5.  Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial.

Authors:  Andrea Natali; Lorenzo Nesti; Iacopo Fabiani; Enrico Calogero; Vitantonio Di Bello
Journal:  Cardiovasc Diabetol       Date:  2017-10-12       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.